Intestinal grafts carry large donor lymphoid load that is replaced by recipient cells. The dynamics of this process may influence the tolerance, rejection or graft-versus-host disease. We analysed distribution and turnover of T and B (Lin+) lymphocytes, natural killer (NK) and helper innate lymphoid cells (hILC) in intestinal epithelium (IEp) and lamina propia (LP) from a long-term cohort of eight intestinal recipients and from a single patient monitored deeply during the first 8 months post-transplant (posTx). Long-term intestinal grafts showed significantly higher %hILC than native bowels in IEp and LP until 10 years posTx and recovery to normal levels was observed afterwards. We also observed an imbalance between hILC subsets in IEp [increase of type 1 (ILC1) and decrease in type 3 (ILC3) innate lymphoid cells] that persisted along posTx time even when %hILC was similar to native bowels. Regarding hILC origin, we still detected the presence of donor cells at 13 years posTx. However, this chimerism was significantly lower than in Lin+ and NK populations. According to these findings, observation from the patient monitored in early posTx period showed that recipient hILC repopulate earlier and faster than Lin+ cells, with increase in ILC1 related to rejection and infection episodes.

Conflicts of interest

The authors of this manuscript have no conflicts of interest to disclose.

Supporting Information

References

1Matsumoto CS, Subramanian S, Fishbein TM. Adult intestinal transplantation. Gastroenterol Clin North Am 2018; 47: 341.
10.1016/j.gtc.2018.01.011
PubMed Web of Science® Google Scholar
2Kubal CA, Mangus RS, Tector AJ. Intestine and multivisceral transplantation: current status and future directions. Curr Gastroenterol Rep 2015; 17: 427.
10.1007/s11894-014-0427-8
PubMed Google Scholar
3Huard G, Schiano TD, Moon J, Iyer K. Severe acute cellular rejection after intestinal transplantation is associated with poor patient and graft survival. Clin Transplant 2017; 31: e12956.
10.1111/ctr.12956
CAS Web of Science® Google Scholar
4Ruiz P. Updates on acute and chronic rejection in small bowel and multivisceral allografts. Curr Opin Organ Transplant 2014; 19: 293.
10.1097/MOT.0000000000000075
PubMed Web of Science® Google Scholar
5Rege A, Sudan D. Intestinal transplantation. Best Pract Res Clin Gastroenterol 2016; 30: 319.
10.1016/j.bpg.2016.02.010
PubMed Web of Science® Google Scholar
6Ganoza A, Mazariegos GV, Khanna A. Current status of graft-versus-host disease after intestinal transplantation. Curr Opin Organ Transplant 2019; 24: 199.
10.1097/MOT.0000000000000624
PubMed Web of Science® Google Scholar
7Shin CR, Nathan J, Alonso M, et al. Incidence of acute and chronic graft-versus-host disease and donor T-cell chimerism after small bowel or combined organ transplantation. J Pediatr Surg 2011; 46: 1732.
10.1016/j.jpedsurg.2011.04.016
PubMed Web of Science® Google Scholar
8Nassif S, Kaufman S, Vahdat S, et al. Clinicopathologic features of post-transplant lymphoproliferative disorders arising after pediatric small bowel transplant. Pediatr Transplant 2013; 17: 765.
10.1111/petr.12150
CAS PubMed Web of Science® Google Scholar
9Ramos E, Hernandez F, Andres A, et al. Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: incidence, clinical features and outcome. Pediatr Transplant 2013; 17: 472.
10.1111/petr.12103
CAS PubMed Web of Science® Google Scholar
10Stanley K, Friehling E, Ranganathan S, Mazariegos G, McAllister-Lucas LM, Sindhi R. Post-transplant lymphoproliferative disorder in pediatric intestinal transplant recipients: a literature review. Pediatr Transplant 2018; 22: e13211.
10.1111/petr.13211
PubMed Web of Science® Google Scholar
11Timpone JG Jr, Girlanda R, Rudolph L, Fishbein TM. Infections in intestinal and multivisceral transplant recipients. Infect Dis Clin North Am 2013; 27: 359.
10.1016/j.idc.2013.02.012
PubMed Web of Science® Google Scholar
12Florescu DF, Langnas AN, Sandkovsky U. Opportunistic viral infections in intestinal transplantation. Expert Rev Anti Infect Ther 2013; 11: 367.
10.1586/eri.13.25
CAS PubMed Web of Science® Google Scholar
13Ziring D, Tran R, Edelstein S, et al. Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation 2005; 79: 702.
10.1097/01.TP.0000154911.15693.80
PubMed Web of Science® Google Scholar
14Timpone JG, Yimen M, Cox S, et al. Resistant cytomegalovirus in intestinal and multivisceral transplant recipients. Transpl Infect Dis 2016; 18: 202.
10.1111/tid.12507
CAS PubMed Web of Science® Google Scholar
15Florescu DF, Sandkovsky U. Fungal infections in intestinal and multivisceral transplant recipients. Curr Opin Organ Transplant 2015; 20: 295.
10.1097/MOT.0000000000000188
PubMed Web of Science® Google Scholar
16Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011; 12: 21.
10.1038/ni.1962
CAS PubMed Web of Science® Google Scholar
17Hazenberg MD, Spits H. Human innate lymphoid cells. Blood 2014; 124: 700.
10.1182/blood-2013-11-427781
CAS PubMed Web of Science® Google Scholar
18Mjosberg J, Spits H. Human innate lymphoid cells. J Allergy Clin Immunol 2016; 138: 1265.
10.1016/j.jaci.2016.09.009
CAS PubMed Web of Science® Google Scholar
19Artis D, Spits H. The biology of innate lymphoid cells. Nature 2015; 517: 293.
10.1038/nature14189
CAS PubMed Web of Science® Google Scholar
20Bernink JH, Peters CP, Munneke M, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013; 14: 221.
10.1038/ni.2534
CAS PubMed Web of Science® Google Scholar
21Moro K, Kabata H, Tanabe M, et al. Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat Immunol 2016; 17: 76.
10.1038/ni.3309
CAS PubMed Web of Science® Google Scholar
22Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464: 1367.
10.1038/nature08900
CAS PubMed Web of Science® Google Scholar
23Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457: 722.
10.1038/nature07537
CAS PubMed Web of Science® Google Scholar
24Cupedo T, Crellin NK, Papazian N, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009; 10: 66.
10.1038/ni.1668
CAS PubMed Web of Science® Google Scholar
25Fuchs A, Vermi W, Lee JS, et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 2013; 38: 769.
10.1016/j.immuni.2013.02.010
CAS PubMed Web of Science® Google Scholar
26Halim TY, Krauss RH, Sun AC, Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012; 36: 451.
10.1016/j.immuni.2011.12.020
CAS PubMed Web of Science® Google Scholar
27Teunissen MBM, Munneke JM, Bernink JH, et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 2014; 134: 2351.
10.1038/jid.2014.146
CAS PubMed Web of Science® Google Scholar
28Boulenouar S, Michelet X, Duquette D, et al. Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity. Immunity 2017; 46: 273.
10.1016/j.immuni.2017.01.008
CAS PubMed Web of Science® Google Scholar
29Simoni Y, Newell EW. Dissecting human ILC heterogeneity: more than just three subsets. Immunology 2018; 153: 297.
10.1111/imm.12862
CAS PubMed Web of Science® Google Scholar
30Jiao Y, Huntington ND, Belz GT, Seillet C. Type 1 innate lymphoid cell biology: lessons learnt from natural killer cells. Front Immunol 2016; 7: 426.
10.3389/fimmu.2016.00426
PubMed Web of Science® Google Scholar
31Talayero P, Mancebo E, Calvo-Pulido J, et al. Innate lymphoid cells groups 1 and 3 in the epithelial compartment of functional human intestinal allografts. Am J Transplant 2016; 16: 72.
10.1111/ajt.13435
CAS PubMed Web of Science® Google Scholar
32Zuber J, Shonts B, Lau SP, et al. Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome. Sci Immunol 2016; 1: eaah3732.
10.1126/sciimmunol.aah3732
PubMed Web of Science® Google Scholar
33Weiner J, Zuber J, Shonts B, et al. Long-term persistence of innate lymphoid cells in the gut after intestinal transplantation. Transplantation 2017; 101: 2449.
10.1097/TP.0000000000001593
PubMed Web of Science® Google Scholar
34Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009; 250: 567.
10.1097/SLA.0b013e3181b67725
PubMed Web of Science® Google Scholar
35Leon F. Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease. J Immunol Methods 2011; 363: 177.
10.1016/j.jim.2010.09.002
CAS PubMed Web of Science® Google Scholar
36Schreurs R, Drewniak A, Bakx R, et al. Quantitative comparison of human intestinal mononuclear leukocyte isolation techniques for flow cytometric analyses. J Immunol Methods 2017; 445: 45.
10.1016/j.jim.2017.03.006
CAS PubMed Web of Science® Google Scholar
37Seillet C, Belz GT, Huntington ND. Development, homeostasis, and heterogeneity of NK cells and ILC1. Curr Top Microbiol Immunol 2016; 395: 37.
CAS PubMed Web of Science® Google Scholar
38Bar-Ephraim YE, Koning JJ, Burniol Ruiz E, et al. CD62L is a functional and phenotypic marker for circulating innate lymphoid cell precursors. J Immunol 2019; 202: 171.
10.4049/jimmunol.1701153
CAS PubMed Web of Science® Google Scholar
39Lim AI, Li Y, Lopez-Lastra S, et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell 2017; 168: 1086.e10.
10.1016/j.cell.2017.02.021
CAS PubMed Web of Science® Google Scholar
40Gomez-Massa E, Talayero P, Utrero-Rico A, et al. Number and function of circulatory helper innate lymphoid cells are unaffected by immunosuppressive drugs used in solid organ recipients. Transplant Int 2020; 33: 402.
10.1111/tri.13567
CAS PubMed Web of Science® Google Scholar
41Wang C, Li Q, Li J. Gut microbiota and its implications in small bowel transplantation. Front Med 2018; 12: 239.
10.1007/s11684-018-0617-0
PubMed Web of Science® Google Scholar
42Hartman AL, Lough DM, Barupal DK, et al. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci USA 2009; 106: 17187.
10.1073/pnas.0904847106
CAS PubMed Web of Science® Google Scholar
43Oh PL, Martinez I, Sun Y, Walter J, Peterson DA, Mercer DF. Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants. Am J Transplant 2012; 12: 753.
10.1111/j.1600-6143.2011.03860.x
CAS PubMed Web of Science® Google Scholar
44Kroemer A, Elsabbagh AM, Matsumoto CS, Zasloff M, Fishbein TM. The microbiome and its implications in intestinal transplantation. Curr Opin Organ Transplant 2016; 21: 135.
10.1097/MOT.0000000000000278
CAS PubMed Web of Science® Google Scholar
45Mathew JM, Tryphonopoulos P, DeFaria W, et al. Role of innate and acquired immune mechanisms in clinical intestinal transplant rejection. Transplantation 2015; 99: 1273.
10.1097/TP.0000000000000491
CAS PubMed Web of Science® Google Scholar
46Ranganathan S, Ashokkumar C, Ningappa M, Schmitt L, Higgs BW, Sindhi R. The transcription factor, T-bet, primes intestine transplantation rejection and is associated with disrupted mucosal homeostasis. Transplantation 2015; 99: 890.
10.1097/TP.0000000000000445
CAS PubMed Web of Science® Google Scholar
47Weizman OE, Adams NM, Schuster IS, et al. ILC1 confer early host protection at initial sites of viral infection. Cell 2017; 171: 795.e12.
10.1016/j.cell.2017.09.052
CAS PubMed Web of Science® Google Scholar
48Picarda G, Ghosh R, McDonald B, et al. Cytomegalovirus evades TRAIL-mediated innate lymphoid cell 1 defenses. J Virol 2019; 93: 16.
10.1128/JVI.00617-19
Web of Science® Google Scholar
49Kim CH, Hashimoto-Hill S, Kim M. Migration and tissue tropism of innate lymphoid cells. Trends Immunol 2016; 37: 68.
10.1016/j.it.2015.11.003
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume33, Issue9

September 2020

Pages 1016-1029

Donor helper innate lymphoid cells are replaced earlier than lineage positive cells and persist long-term in human intestinal grafts – a descriptive study

Summary

Conflicts of interest

Supporting Information

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Donor helper innate lymphoid cells are replaced earlier than lineage positive cells and persist long-term in human intestinal grafts – a descriptive study

Summary

Conflicts of interest

Supporting Information

References

Citing Literature

References

Related

Information